secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001808805-24-000043
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nautilus Biotechnology announces 2024 annual meeting voting results
-------------------------------------------------------------------

- Elected Melissa Epperly (92.1M for, 674K withheld), Matthew L. Posard (90.6M for, 2.1M withheld), Karen Akinsanya (89.9M for, 2.8M withheld) as Class III directors.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2024 with 105.1M votes for, 172.9K against, 69.2K abstentions.
- Approximately 84% of outstanding shares (105.3M of 125.3M) represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000180880524000043/0001808805-24-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000180880524000043/naut-20240613.htm
  HTML page:      https://secwatch.observer/filing/0001808805-24-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer